Exchange Traded Concepts LLC increased its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 206.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,645 shares of the conglomerate's stock after buying an additional 15,256 shares during the quarter. Exchange Traded Concepts LLC's holdings in Danaher were worth $4,642,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Factory Mutual Insurance Co. increased its holdings in shares of Danaher by 5.0% in the 1st quarter. Factory Mutual Insurance Co. now owns 216,800 shares of the conglomerate's stock worth $44,444,000 after acquiring an additional 10,400 shares during the period. Compass Capital Management Inc. grew its position in Danaher by 10.8% in the 1st quarter. Compass Capital Management Inc. now owns 263,615 shares of the conglomerate's stock worth $54,041,000 after purchasing an additional 25,693 shares during the last quarter. SFM LLC acquired a new stake in shares of Danaher in the first quarter valued at approximately $1,899,000. Prentice Wealth Management LLC raised its holdings in shares of Danaher by 3.8% during the first quarter. Prentice Wealth Management LLC now owns 2,941 shares of the conglomerate's stock valued at $603,000 after buying an additional 107 shares during the last quarter. Finally, Foster Victor Wealth Advisors LLC boosted its position in shares of Danaher by 33.7% during the first quarter. Foster Victor Wealth Advisors LLC now owns 70,881 shares of the conglomerate's stock worth $13,377,000 after buying an additional 17,852 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Danaher
In other news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.
Danaher Stock Performance
DHR stock opened at $200.51 on Monday. The firm has a 50 day simple moving average of $192.80 and a 200 day simple moving average of $210.81. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The stock has a market cap of $143.50 billion, a P/E ratio of 37.98, a P/E/G ratio of 2.66 and a beta of 0.77. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.
Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.64%. Danaher's payout ratio is currently 24.85%.
Analyst Upgrades and Downgrades
Several analysts have weighed in on DHR shares. Wells Fargo & Company cut their target price on Danaher from $240.00 to $210.00 and set an "equal weight" rating on the stock in a research note on Wednesday, April 23rd. Citigroup restated a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Evercore ISI decreased their target price on shares of Danaher from $240.00 to $230.00 and set an "outperform" rating for the company in a research report on Tuesday, April 22nd. TD Cowen boosted their price target on shares of Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and a consensus target price of $248.17.
Read Our Latest Stock Report on DHR
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
